NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...

Pelthos Therapeutics Inc. ( PTHS) Q4 2025 Earnings Call March 19, 2026 8:00 AM EDT ...

LexinFintech Holdings Ltd. ("Lexin" or the "Company") (NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today ...

A man seen in a viral video bearing a striking resemblance to Jeffrey Epstein has clarified that he is not the disgraced financier, identifying himself as "Palm Beach Pete." ...

Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half ...

FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in ...

Orla Mining Ltd. (TSX: OLA) (NYSE: ORLA) ("Orla" or the "Company") today announces the results for the fourth quarter and year ended December 31, 2025.

BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “Alibaba” or “Alibaba Group”) today announced its financial results for the quarter ended December 31, 2025. “This quarter, Alibaba ...

Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half ...

Calamos CPZ reported a Q4 total return of -2.05% on NAV as the fund shifted exposure from AI beneficiaries to pro-growth cyclicals. Read the full analysis now.

From "blowout kits" to emergency snacks, experts share the ultimate checklist and organization hacks to ensure you’re prepared for every parenting curveball.

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any ...